Diagnosis of Gastroduodenal Diseases by Proteiomic Fingerprints of Gastric Juice
18 Years
85 Years
Both
Gastric Cancer
Trial Information
Diagnosis of Gastroduodenal Diseases by Proteiomic Fingerprints of Gastric Juice
Patients and methods: The study consisted of two parts: (1) investigating the differences in
gastric juice biomarker concentrations between gastric cancer patients and controls, and (2)
screening gastric cancer using string test to obtain gastric juice followed by immunoassay
for biomarker concentration.
Inclusion Criteria:
- healthy subjects and gastric cancer patients documented by endoscopy.
Exclusion Criteria:
- the use of proton pump inhibitors or histamine-2 receptor antagonists within 4 weeks
prior to the study
- coexistence of two kinds of gastroduodenal lesions
- coexistence of severe systemic diseases
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
accurate diagnosis of gastric cancer or not
Outcome Time Frame:
within 2 months after test
Safety Issue:
No
Principal Investigator
Ping-I Hsu, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kaohsiung Veterans Genaral hospital
Authority:
Taiwan: Institutional Review Board
Study ID:
VGHKS96-CT2-24
NCT ID:
NCT00834236
Start Date:
March 2008
Completion Date:
March 2009
Related Keywords:
- Gastric Cancer
- gastric cancer
- proteomics
- gastric juice
- Stomach Neoplasms
Name | Location |
|---|
